Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2026-01-29 @ 7:22 AM
Study NCT ID:
NCT00642902
Status:
TERMINATED
Last Update Posted:
2016-05-24
First Post:
2008-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
Sponsor:
EMD Serono
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-21
First Submit QC Date:
None
Study First Post Date:
2008-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-15
Results First Submit QC Date:
None
Results First Post Date:
2016-05-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-15
Last Update Post Date:
2016-05-24
Last Update Post Date Type:
ESTIMATED